The assistant professor of biostatistics at Washington University in St. Louis discussed what role the COViMS registry can play for the MS community at this stage in the pandemic.
Amber Salter, MPH, PhD
Advertisement
Assistant professor of biostatistics, Washington University School of Medicine in St. Louis
Articles by Amber Salter, MPH, PhD
Advertisement
Latest Updated Articles
How COViMS Registry Is Clarifying MS COVID-19 Risks: Amber Salter, MPH, PhDPublished: March 4th 2021 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni
2
How Multiple Sclerosis Affects Men
3
Trofinetide Leads to Real-World Improvements in Rett Syndrome Symptoms, LOTUS Study Finds
4
Key Highlights from the 2025 American Neurological Association Annual Meeting
5
